MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair
- PMID: 22978401
- PMCID: PMC3483249
- DOI: 10.1186/1471-2350-13-81
MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair
Abstract
Background: Concomitant primary cutaneous melanoma in monozygotic twins has been reported in only two pairs but in neither of them genetic analysis was performed. Two high-penetrance susceptibility genes, CDKN2A and CDK4 and one low-penetrance gene, MC1R, are well-defined genetic risk factors for melanoma. MITF has been recently identified as a novel intermediate risk melanoma-predisposing gene.
Case presentation: We describe the extraordinary occurrence of a primary cutaneous invasive melanoma in two 44-year-old identical, female twins, on the same body site within 30 days of each other and report for the first time the genetic analysis of melanoma susceptibility genes in both twins. Data on characteristics of the twins were collected through a standardized questionnaire and skin examination. Exons 1α, 1β, 2 and 3 of CDKN2A, exon 2 of CDK4, the entire open reading frame of MC1R and the recently described MITF c.952 G > A (p.Glu318Lys) variant were investigated by direct sequencing. Sequencing analysis of the high-penetrance susceptibility genes showed no changes in CDKN2A and in exon 2 of the CDK4 gene. Both patients were heterozygous for the same CDKN2A UTR c.*29C > G variant. Interestingly, the same two heterozygous variants of the MC1R were identified in both twins: the c.451C > T (p.Arg151Cys) and the c.456C > A (p.Tyr152*) variants. Neither patient showed the c.952 G > A (p.Glu318Lys) substitution in the MITF gene.
Conclusions: Identification of two high-risk MC1R variants in our identical twins in the absence of CDKN2A and CDK4 mutations highlights the contribution of low penetrance genes, such as MC1R, in melanoma susceptibility.
Figures

Similar articles
-
Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.Br J Dermatol. 2016 Nov;175(5):1030-1037. doi: 10.1111/bjd.14897. Epub 2016 Aug 31. Br J Dermatol. 2016. PMID: 27473757
-
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.Melanoma Res. 2006 Apr;16(2):175-82. doi: 10.1097/01.cmr.0000198454.11580.b5. Melanoma Res. 2006. PMID: 16567973
-
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients.J Eur Acad Dermatol Venereol. 2022 Feb;36(2):213-221. doi: 10.1111/jdv.17735. Epub 2021 Nov 3. J Eur Acad Dermatol Venereol. 2022. PMID: 34664323
-
MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.Eur J Cancer. 2010 May;46(8):1413-20. doi: 10.1016/j.ejca.2010.01.027. Epub 2010 Feb 26. Eur J Cancer. 2010. PMID: 20189796 Review.
-
High- and low-penetrance cutaneous melanoma susceptibility genes.Expert Rev Anticancer Ther. 2006 May;6(5):657-70. doi: 10.1586/14737140.6.5.657. Expert Rev Anticancer Ther. 2006. PMID: 16759158 Review.
Cited by
-
Evaluation of MC1R high-throughput nucleotide sequencing data generated by the 1000 Genomes Project.Genet Mol Biol. 2017 Apr-Jun;40(2):530-539. doi: 10.1590/1678-4685-GMB-2016-0180. Epub 2017 May 8. Genet Mol Biol. 2017. PMID: 28486572 Free PMC article.
-
Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype.J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1768-75. doi: 10.1111/jdv.12411. Epub 2014 Mar 4. J Eur Acad Dermatol Venereol. 2014. PMID: 24588892 Free PMC article.
References
-
- Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon Albright LA, Demenais F, Elder DE, Ghiorzo P, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, Mackie RM, Magnusson V, Mann GJ, Niendorf K, Newton Bishop J, Palmer JM, Puig S, Puig-Butille JA, de Snoo FA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E. Melanoma Genetics Consortium (GenoMEL) High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res. 2006;66:9818–9828. doi: 10.1158/0008-5472.CAN-06-0494. - DOI - PubMed
-
- Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S, Zismann V, Gartside M, Cust AE, Haq R, Harland M, Taylor JC, Duffy DL, Holohan K, Dutton-Regester K, Palmer JM, Bonazzi V, Stark MS, Symmons J, Law MH, Schmidt C, Lanagan C, O'Connor L, Holland EA, Schmid H, Maskiell JA, Jetann J, Ferguson M, Jenkins MA, Kefford RF, Giles GG, Armstrong BK, Aitken JF, Hopper JL, Whiteman DC, Pharoah PD, Easton DF, Dunning AM, Newton-Bishop JA, Montgomery GW, Martin NG, Mann GJ, Bishop DT, Tsao H, Trent JM, Fisher DE, Hayward NK, Brown KM. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature. 2011;480:99–103. doi: 10.1038/nature10630. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous